Related Experiment Video
Updated: Jun 12, 2026
05:26
Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction
Published on: May 28, 2019
Postconditioning in acute myocardial infarction patients.
Fabrice Ivanes1, Gilles Rioufol, Christophe Piot
1INSERM U886, CIC de Lyon, Hospices Civils de Lyon, Université Claude Bernard Lyon, Lyon, France.
Antioxidants & Redox Signaling
|June 29, 2010
Summary
Reperfusion therapy for acute myocardial infarction (AMI) can cause damage. Postconditioning methods, including angioplasty and cyclosporine A, show promise in reducing this injury and protecting heart muscle.
Area of Science:
- Cardiology
- Cardiovascular Research
- Ischemic Heart Disease
Background:
- Reperfusion therapy is crucial for acute myocardial infarction (AMI) but can cause additional myocardial damage.
- This damage is linked to the opening of the mitochondrial permeability transition pore.
- Ischemic postconditioning emerges as a novel strategy to mitigate lethal reperfusion injury.
Purpose of the Study:
- To evaluate the protective effects of postconditioning in patients with AMI.
- To explore angioplasty postconditioning and pharmacological postconditioning as therapeutic strategies.
- To assess the potential of cyclosporine A as a mitochondrial permeability transition pore inhibitor for myocardial protection.
Main Methods:
- Review of clinical studies on angioplasty postconditioning in AMI patients.
- Investigation of pharmacological postconditioning, specifically using cyclosporine A.
- Analysis of evidence linking reperfusion injury to mitochondrial permeability transition pore opening.
Main Results:
- Clinical studies support the protective effects of angioplasty postconditioning in AMI patients.
- Cyclosporine A, a mitochondrial permeability transition pore inhibitor, demonstrated comparable protection in AMI patients.
- Pharmacological postconditioning offers a potential alternative applicable to a broader patient population.
Conclusions:
- Postconditioning, both mechanical (angioplasty) and pharmacological (cyclosporine A), shows significant promise in reducing reperfusion injury in AMI.
- Further large-scale trials are necessary to confirm the clinical benefits of postconditioning on patient outcomes in ST-segment elevation MI.
- Targeting the mitochondrial permeability transition pore is a viable strategy for myocardial protection during reperfusion.
Related Concept Videos
01:28Acute Coronary Syndrome IV: Interprofessional Care
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
01:30Acute Coronary Syndrome III: Diagnostic Studies
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
01:19Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...